Ellen O'Connor Vos, Director at OptimizeRx Corp (OPRX), bought 1,800 shares at $10.47 ($19K) on 2018-06-25, disclosed to the SEC on 2018-06-27.
Open-market purchase of $19k OPRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.29 | 50 | $515 | 2.7% |
| 2 | $10.35 | 400 | $4K | 22.0% |
| 3 | $10.47 | 1,100 | $12K | 61.1% |
| 4 | $10.72 | 250 | $3K | 14.2% |
| Total | $10.47 avg | 1,800 | $19K | 100% |
| Filing → |
| MODD | BUY | 2021-11-01 | $300K | — | Filing → |
| OPRX | BUY | 2020-04-01 | $9K | — | Filing → |
| OPRX | BUY | 2019-11-14 | $6K | — | Filing → |